Alternatives to Omda Cytodose

The successful evaluation of drug treatments and their protocols hinges on the effective gathering and sharing of thorough, timely, and high-quality data. To support this need, the Omda Compos suite of solutions is specifically crafted to enhance the management and effortless exchange of medical information across the clinical landscape. This innovative platform guarantees that users and applications involved in clinical trials and registries have easy access to vital data, fostering improved collaboration and effective data usage. At the heart of the Compos platform lies Omda Compos QR, which features a sophisticated database structure, data warehousing functions, user management, and other critical elements that uphold data integrity throughout the entire process, from collection to analysis. Maintaining streamlined user access and efficient logging practices is crucial for any clinical registry or trial. Within Omda Compos QR, user roles are defined to regulate access to designated sites, thereby enhancing security and control over the data management process. By prioritizing these features, the platform not only supports researchers but also improves the overall quality of clinical data handling.

AZZLY Rize is the premier clinical and business platform for addiction treatment and mental health organizations. As a modern technology platform, AZZLY Rize is a system that can scale with you. Use as little or as many of the features and functions available based on your program and staff needs. Key features for OUTPATIENT Programs include e-check-in, scheduling, appointment reminder, Zoom telehealth, treatment plans, progress notes, assessments and surveys. For RESIDENTIAL Programs: census, medication management, bed board, withdrawal management, DrFirst e-prescribing, EPCS, PDMP and labs. For all Programs: alerts, patient engagement, 5 star implementation and support services, and seamless electronic billing and claims submission. As a true all-in-one platform, we empower treatment centers to take control of their compliance and revenue cycle management and reporting requirements. As a purpose-built tool for mental health and substance use disorder programs, we offer a flexible pricing plan to replace dated technology. Use our compliant Master Library of Forms or we configure your documentation forms to match what you use today. Hosted in Microsoft Azure Private Cloud Network for added security and HIPAA privacy.

Omda MedSciNet solutions enhance the quality, usability, and administration of medical data throughout its lifecycle from collection to analysis. This secure and standardized software streamlines the process for clinical researchers and other professionals in healthcare and academia, allowing for the efficient gathering and examination of well-organized medical data. The dedicated Omda team excels in the development and management of customized database applications, as well as designing clinical studies tailored for medical research and quality registries. The Omda MedSciNet study platform offers a dependable, feature-rich, and highly adaptable online environment suitable for hosting and managing complex study and clinical trial systems. With a proven track record spanning 20 years, Omda MedSciNet has effectively supported studies and clinical trials of various scopes and sizes. Standard implementations come equipped with a comprehensive array of components essential for launching fully functional studies or clinical trials, ensuring that researchers have all the necessary tools at their disposal. This commitment to quality and customization positions Omda MedSciNet as a leader in the field of medical data management.

Omda Fertsoft offers a holistic software solution designed to aid fertility clinics in efficiently recording, managing, and utilizing both patient and treatment information. From the initial contact through to the completion of treatment, Omda Fertsoft ensures a user-friendly and customizable platform for data entry, retrieval, and analysis. The software encompasses administrative and business operations, addressing all facets of clinic management, which fosters improved collaboration among teams. Tailored to the specific needs of each clinic, our modular design allows for a highly adaptable setup that can be modified instantly. Built for sustained value in a rapidly evolving sector, we actively engage with our clients to continuously enhance Omda Fertsoft. Consequently, the software not only improves the patient journey but also supports healthcare professionals in making informed clinical decisions while optimizing overall clinic management. This commitment to innovation and customer feedback positions Omda Fertsoft as a leader in fertility clinic software solutions.

Charm Evolution serves as a comprehensive oncology information management system that centralizes all processes related to chemotherapy prescribing and administration, thereby improving safety, consistency, and accountability by substituting handwritten orders with digital prescriptions that are meticulously monitored through order adjustments and orphan management for precise wastage reporting. It consolidates accurate and secure patient records and treatment data from various sources into a unified database, facilitating informed and efficient decision-making directly at the point of care. Furthermore, an intelligent pathway engine automates treatment protocols, enhances scheduling in accordance with regimens, and caters to both adult and pediatric oncology and hematology through customizable treatment libraries, protocol validation, and management of clinical trials. Additionally, integrated pharmacy management offers bi-directional connectivity with compounders, along with the option to customize worksheets and labels, while the scheduling component maximizes resource allocation and minimizes the need for patient travel, ultimately contributing to a more effective healthcare delivery system. This holistic approach fosters an environment where healthcare providers can deliver optimal care to their patients.

Mosaiq serves as an all-encompassing oncology information system and electronic medical record platform that oversees every aspect of cancer care, ranging from diagnosis and treatment strategy formulation to implementation, follow-up, and outcome reporting. This system consolidates clinical, operational, and financial information into one cohesive database, enabling healthcare professionals to obtain comprehensive patient records and enhance collaboration across various specialties, including radiation oncology and medical oncology. Moreover, it facilitates essential workflows like chemotherapy order management, radiation therapy planning and execution, scheduling, billing, and clinical documentation, while also equipping users with decision support tools and customizable workflows to streamline routine processes and boost precision. By integrating these capabilities, Mosaiq significantly enhances the efficiency and effectiveness of cancer care delivery.

Our software products are crafted for simplicity and quick comprehension. User-friendly interfaces, developed in collaboration with Oncologists, are designed to maximize efficiency and save valuable time. We implement robust systems aimed at improving patient safety while introducing innovative modules that push the boundaries of research. Automation is at the heart of our solutions, facilitating everything from chemotherapy order planning to staff management. We provide a thorough solution tailored for cancer centers, optimizing the Oncology workflow seamlessly. With our platform, generating accurate chemotherapy orders is a swift and uncomplicated process. Our extensive protocol library boasts over 1000 regularly updated protocols. The system automatically calculates and confirms drug doses and infusion rates while being rigorously tested and CE marked for quality assurance. All doses are verified twice, and checks for drug-drug and drug-allergy interactions are included. Patient-drug matching is enhanced through QR coded labels, significantly reducing medication errors. Users can conveniently view the active chemotherapy order, patient diagnosis and stage, the latest lab results, and the chemotherapy flowsheet all on a single screen, ensuring a comprehensive overview at a glance. This streamlined approach promotes efficiency and safety in Oncology practice.

Omda ProSang is a sophisticated Laboratory Information Management System (LIMS) designed for comprehensive management of blood, cells, and tissues, ensuring complete traceability from the donor to the recipient. This system is employed in various settings, including blood donation centers, immunohematology and clinical immunology laboratories, transplantation facilities, tissue establishments, and stem cell centers. With decades of reliable support for ISBT 128, Omda ProSang is a trusted solution for over 180 blood centers across five nations. It delivers a thoroughly documented process along with full traceability, which enhances oversight of the entire donor-to-recipient journey. The automation of processes significantly streamlines testing and analysis workflows while facilitating effective communication with donors. Additionally, the platform is equipped with robust safety mechanisms aimed at enhancing patient safety, and it features comprehensive statistics and analytical tools that empower healthcare providers to optimize their resource utilization. Overall, Omda ProSang stands out as an essential tool in modern transfusion medicine.

The ARIA® oncology information system is designed to assist both medical and radiation oncology practitioners, including those utilizing proton therapy. It enables the review of clinical images, prescriptions, lab results, quality assurance, treatment outcomes, and much more. Additionally, it automates cancer staging in accordance with AJCC guidelines and allows for flexible management of treatment toxicities. With a strong emphasis on interoperability, ARIA ensures that patient data can be utilized effectively across various devices and platforms. It provides comprehensive support for HL7 and DICOM standards, simplifying the transfer of patient data between healthcare facilities. This system grants your teams immediate access to patient information, enhancing their ability to plan and make real-time adjustments as needed. Furthermore, ARIA OIS aids in optimizing image-guided treatment techniques by utilizing radiographic, fluoroscopic, and cone-beam CT images. It also documents activities to support evidence-based Pay-for-Performance initiatives while ensuring compliance with HIPAA regulations. By efficiently storing and organizing patient data and images, ARIA enables your teams to remain informed and dedicated to providing high-quality care for their patients. This innovative system ultimately streamlines workflows, allowing healthcare providers to focus on what truly matters: patient outcomes and well-being.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

EpiSoft is a provider of cloud-based medical software that caters to a variety of healthcare fields, such as oncology, mental health, hospital preadmissions, hepatitis, and inflammatory bowel disease. Their comprehensive platform encompasses electronic medical records (EMR), practice management, infusion drug oversight, and portals designed for patient engagement. Notably, EpiSoft's EMR is equipped with features that ensure integration with Medicare, health insurance funds, and the Department of Veterans' Affairs (DVA), which facilitates quicker claim processing. Additionally, it includes a scheduling module specifically designed for intricate care plans, like those involving chemotherapy cycles, along with electronic prescriptions that streamline medication management. The cloud-based nature of their service permits access from any device, while automated SMS and email reminders for appointments significantly reduce the likelihood of no-shows and cancellations. Furthermore, the patient portal seamlessly connects with existing hospital websites and patient administration systems, allowing for the direct capture of validated health histories and demographic information from patients, which ultimately alleviates administrative workloads. This innovative approach not only enhances efficiency but also improves the overall patient experience in healthcare settings.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Enhance the effectiveness and efficiency of cancer care throughout various healthcare environments. Developed in close partnership with cancer specialists, iKnowMedSM serves as an electronic health record (EHR) that seamlessly offers essential patient information precisely when it’s needed, accessible on nearly any device. Featuring the latest advancements in user interface design and an unparalleled mobile platform, iKnowMed EHR delivers extensive point-of-care treatment decision support alongside customizable features that easily fit into current workflows. Empower your patients with thorough clinical assistance by utilizing a constantly refreshed repository of oncology treatment protocols, drug availability, and clinical outcomes. Gain access to evidence-based clinical guidelines and pathways precisely when required, ensuring timely and effective decision-making. Furthermore, keep your treatment options current by integrating data on treatment expenses, insurance coverage, and reimbursement information, thereby supporting both patients and healthcare providers in navigating the complexities of cancer treatment. In doing so, practices can significantly improve patient outcomes and streamline the overall care process.

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.

No matter the scale of your clinic or your location, MOSAIQ Plaza* equips you with the essential digital tools to provide exceptional multidisciplinary care for your patients—ensuring consistency, reliability, and security throughout their journey from diagnosis to survivorship while generating valuable real-world evidence. Elekta has introduced robust solution packages designed to boost your team's ability to provide care and optimize treatment workflows, allowing you to concentrate on your primary focus: your patients. As we pave the way for the future of multidisciplinary cancer care, MOSAIQ 3 establishes new benchmarks in oncology workflow and information management. Experience the advantages of effortless access to the MOSAIQ Plaza environment, which leads to remarkable efficiencies and a more streamlined operational experience, ultimately enhancing patient outcomes and satisfaction.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

Spend more quality time engaging with your patients while minimizing your interactions with electronic health records, as OncoEMR® prioritizes workflow efficiency and rapid processing. The platform is tailored for oncology practices, featuring specialized workflows and tools like Document Search that streamline tasks, cutting down work duration from minutes to mere seconds. With the introduction of MIPS, OncoEMR® provides essential resources to navigate the program successfully, assisting in the collection and reporting of mandatory data while offering support throughout the workflows and official reporting obligations. Designed specifically for community oncology practices, OncoEMR® incorporates elements such as NCCN Chemotherapy Order Templates® and the latest AJCC disease factors, transforming it into a bespoke diagnostic and treatment resource. Prior to launching OncoEMR®, Flatiron will handle the migration of your existing EHR database, allowing for a seamless transition on your first day of operation. After the migration process, you will benefit from over 150 preloaded reports, enabling you to gain valuable insights into both business operations and clinical metrics, including patient wait times, ensuring a comprehensive understanding of your practice's performance. This combination of tools and features not only enhances efficiency but also supports improved patient care and outcomes in your oncology practice.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

PEPID has been providing web-based point of care solutions for healthcare professionals for more than 20 years. These solutions allow them to accurately dose patients and diagnose medical conditions, as well as detect drug interactions and allergic reactions. PEPID products are integrated into the systems of hospitals, universities, schools, and clinics around the globe. PEPID simplifies medical information with a built-in workflow that was developed over years of interaction with pharmacists, doctors, and nurses. This unmatched organization allows healthcare professionals to have faster access and better clinical performance. It also gives them greater mobility. PEPID is used by schools to improve learning in the classroom, clinical, or study setting. PEPID is a better risk management system, greater productivity, and higher staff and patient satisfaction.

Deeplink Medical has centered its offerings around the MIRIO platform, which is designed to cater to the varying use cases and requirements of stakeholders engaged in medical imaging within oncology, both in clinical settings and routine practice. Our services encompass three distinct yet interconnected solutions: MIRIO, which tracks evaluations of solid tumors and monitors the therapeutic responses of oncology patients; a streamlined patient pathway that bridges hospital facilities with private medical practices; and an Imaging CRO dedicated to the oversight of imaging data in oncological clinical trials. The development of our innovative solutions is bolstered by a scientific board, ensuring a robust foundation for our offerings. Additionally, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, facilitating real-time data structuration in accordance with RECIST 1.1 and iRECIST guidelines right from the moment the data is generated at investigation sites. This enables immediate evaluation of treatment responses based on established international standards, ultimately enhancing the quality and efficiency of patient care in oncology. By integrating these services, we aim to provide a comprehensive approach that supports healthcare professionals in delivering optimal treatment outcomes.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Sargas Pharmaceutical Adherence and Compliance (SPAC) International has created an innovative Chronic Care Management Cloud® platform (CCM), alongside its Drug Adherence®, Medication Therapy Monitoring® (MTM), and Mobile Oncology Medication Therapy Monitoring® technologies, to ensure continuous engagement between physicians and patients from the outset of treatment throughout the entire process. This collaborative treatment management strategy not only helps patients maximize their health benefits and achieve optimal outcomes but also contributes to lowering healthcare costs for the system as a whole. Additionally, SPAC offers HIPAA Compliant and certified Chronic Care Management Physician, Patient, and Pharmacy Portals® that facilitate the real-time exchange of essential patient health information among various healthcare providers, ensuring a seamless flow of information critical for effective treatment. Such advancements in technology greatly enhance the overall quality of care delivered to patients.

Our comprehensive suite of products links clinics and physicians to the necessary pharmacies and laboratories for effective treatment delivery. The offerings 1to1Clinic, 1to1MD, and 1to1Pharmacy are designed to be fully mobile-compatible and adhere to HIPAA standards, enabling your practice to offer online medical services, electronic diagnoses, e-prescriptions, and more at any hour of the day throughout the year. This innovative medical software provides the results that both you and your patients seek and deserve. With features that enhance mobile collaboration, patient outreach, and engagement strategies for clinicians, doctors, and pharmacists alike, EhealthGlobal equips you with user-friendly tools essential for secure communication, accurate diagnosis, and effective treatment administration. Additionally, this platform ensures that all interactions occur within a completely secure environment, reinforcing trust and reliability in patient care.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Noona® offers a comprehensive management solution for patient outcomes that actively involves patients in their treatment through immediate symptom reporting and monitoring, enhanced clinical workflows that support evidence-based practices, and access to extensive data insights for improved ongoing care management. Patients have the freedom to report their symptoms, fill out questionnaires, and engage with their healthcare teams whenever they wish. This approach enables care teams to gather highly specific and detailed data tailored to each patient's diagnosis and treatment plan, facilitating better-informed decision-making. With the benefit of automated prioritization, healthcare providers can identify and respond to patients who require urgent attention. The platform features over 31 treatment modules that encompass more than 97 prevalent cancer types, complemented by 244 algorithms that assess symptom severity according to established guidelines. Additionally, its remote deployment capabilities ensure quick implementation and immediate access for patients to start using the system. This innovative solution ultimately enhances the overall quality of patient care and outcomes throughout the treatment journey.

Enhance the Patient Journey by actively engaging, educating, and empowering individuals through improved health communications. Utilize a Patient Engagement Platform to tailor optimal care plans for various medical pathways, such as prostate and breast cancer. Develop a Patient Engagement Pathway that organizes communication strategies in accordance with each care plan's requirements. Streamline the organization of communications by creating or sourcing a variety of supportive materials, including messages, documents, and videos, that correspond to different phases of the care plan. Establish clear communication rules that specify who receives which communications and at what times, ensuring timely delivery of essential information. Integrate new patients into the system effortlessly by matching their specific needs with the appropriate pathway. Finally, centralize all patient-facing communications in one location, allowing for the efficient dissemination of messages, documents, forms, videos, and health widgets. By doing so, healthcare providers can enhance the overall patient experience and foster better health outcomes.

DoseMeRx stands as the first and largest Bayesian dosing platform worldwide, tailored specifically for clinical use. Accelerate your journey toward clinical objectives with our proven platform, which notably enhances patient outcomes while reducing expenses. Uniquely, we are the sole Bayesian dosing solution globally that holds HITRUST certification, providing you with peace of mind regarding the utmost protection and integrity of patient data. Experience seamless continuity of care throughout your healthcare system with just a few simple steps. Easily standardize workflows and fine-tune your therapeutic drug monitoring initiatives. Our diverse array of drug models spans multiple therapeutic fields, such as vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation management, as well as oncology and pediatrics, ensuring comprehensive support for a wide range of clinical scenarios. This versatility empowers healthcare providers to deliver tailored treatment solutions effectively.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

HCS eMAR serves as an electronic medication administration record solution that has been shown to enhance patient safety while significantly decreasing the time required for documentation tasks. Facilities utilizing HCS eMAR report a notable 33% decline in medication administration mistakes alongside a 45% reduction in the time spent on documentation processes. This system allows healthcare professionals to record medication administrations, monitor vital signs, and note other important observations efficiently. Immediate alerts are generated when clinical interventions are necessary, and these notifications can be viewed directly on the eMAR screen, sent via email or pager, included in reports, or displayed on the integrated Status Board. The Status Board, prominently featured on monitors at nursing stations, provides a comprehensive overview of patient rooms that require medication administration, evaluations for medication responses, or updates on vital sign checks. By streamlining these processes, HCS eMAR not only enhances efficiency but also fosters a safer environment for patient care.

MED e-care's eMAR & eTAR presents clients with a cutting-edge and cohesive approach to managing medication and treatment administration, accessible both online and through an offline application that can be synced. This application grants staff secure and easy access to residents' medication records, enabling immediate recording, gathering, and reporting of resident-related data. With the use of bar code technology, nursing personnel can swiftly retrieve resident and medication/treatment details. Moreover, this system minimizes the need for at least five manual clicks for staff, as bar coding automates the reconciliation of the upcoming scheduled medications and treatments with what is actually available in the pouch. Scanning the 2D bar code not only accelerates the process of documenting drug information but also significantly decreases the likelihood of errors that can arise from manually inputting this crucial data into our software, thus enhancing overall efficiency. The integrated features ultimately streamline workflow and improve the quality of care provided to residents.

Legion Health is a modern telepsychiatry service that connects patients with board-certified providers who diagnose and treat the most common mental health conditions, including ADHD, depression, anxiety, bipolar disorder, PTSD, and sleep issues. The company accepts major insurance plans, making high-quality psychiatric care financially accessible for millions of people. New patients can complete a brief intake, browse provider profiles, and schedule a virtual appointment that fits their schedule—often as soon as the next day. During each online visit, clinicians offer thoughtful assessments, medication plans, and ongoing follow-up care tailored to the patient’s needs. Legion Health emphasizes warm, judgement-free support, ensuring every session feels safe and understanding. Prescriptions are managed seamlessly, with medication coordination handled quickly and professionally. Patients also benefit from flexible follow-up options, evening availability, and a team that remains closely engaged throughout treatment. With its blend of convenience, expertise, and empathetic care, Legion Health helps individuals take meaningful steps toward a healthier, more stable life.

Color delivers one of the most user-friendly, high-quality genetic testing services currently on the market, examining genetic markers linked to the likelihood of developing prevalent cancers and heart diseases, as well as how individuals metabolize specific medications. Our comprehensive range of services, tools, and expertise is designed to facilitate the enrollment of new patients and guide them through personalized care journeys that evolve over time. By taking a holistic approach to patient health, we integrate genetic data, personal and family medical histories, along with lifestyle and behavioral factors to identify and suggest tailored care options or solutions that align with each patient's unique risk profile. This multifaceted strategy ensures that patients receive relevant recommendations that can significantly impact their health outcomes.

Medication therapy management (MTM) has been established for over ten years, yet the costs associated with medications continue to rise, the incidence of chronic diseases increases, and the satisfaction levels of health plan members remain flat. In light of these challenges, there is a greater necessity for an effective, scalable solution to manage prescriptions that supports patient health and minimizes expenses linked to medication-related issues. Arine functions as if it were an exceptionally skilled senior addition to your healthcare team, integrating data science with clinical knowledge to provide clinicians with the essential insights, care plans, and tools necessary for delivering tailored patient care. By gathering and synthesizing all relevant information, Arine automates tedious tasks for clinicians, allowing them to dedicate more time to patient counseling and engagement. Moreover, Arine utilizes predictive analytics to foresee high-risk, high-cost occurrences by dissecting risk scores into practical clinical, behavioral, and social factors, thereby enhancing proactive care management. This innovative approach not only streamlines healthcare processes but also contributes to better patient outcomes and overall satisfaction.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Pharmacists initiate a Comprehensive Medication Review at the start of programs to address issues related to medication nonadherence. Patients struggling to manage their diabetes face a significantly higher likelihood of severe complications, increased hospitalizations, and emergency room visits, which also leads to more costly associated health issues. Adhering to prescribed medications is crucial as it helps prevent the failure of transplanted organs, thereby avoiding challenging and costly complications like rejection episodes, infections, graft failure, and the need for retransplantation. emocha serves as the leading standard of care for numerous Tuberculosis programs nationwide. Additionally, emocha proves to be an effective resource for patients managing HIV and HCV medications. Furthermore, emocha aids employers and public health organizations across the nation by facilitating vaccination tracking, monitoring symptoms, conducting contact investigations and tracing, as well as providing a clinical triage service to ensure community safety and health. This multifaceted approach underscores the vital role of technology in enhancing patient care and public health initiatives.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

My Care PlusSM enhances the healthcare experience by fostering a personal connection that allows patients to take charge of their health journey. Through the user-friendly portal, individuals can easily access their personal health records, communicate with their healthcare providers, and explore a newly expanded repository of educational resources designed for patients. Patients are granted the ability to review their comprehensive care plans, along with vital health information and educational materials on conditions and medications sourced from reputable cancer organizations, accessible at any time and from any location. They can also utilize secure messaging to address non-urgent inquiries or send broadcast messages to all patients, ensuring effective communication. To boost patient engagement with the portal, customizable marketing resources, videos, and other tools are available to raise awareness of its advantages. Additionally, the platform supports healthcare practices in achieving Meaningful Use objectives by integrating all necessary features to fulfill both stage 1 and stage 2 requirements. Furthermore, it offers robust clinical decision support, along with performance analytics to enhance practice efficiency and patient care. With this comprehensive suite of services, My Care PlusSM not only improves patient interactions but also enhances the overall quality of care provided.

We assist in standardizing the contouring of organs at risk and automating segmentation in radiotherapy, which enhances the efficiency of cancer treatment planning. By adhering to established consensus guidelines, we ensure that the contours you create are more reliable. Every clinic requires a robust standard, and we take charge of implementing it on your behalf. Our fully automated 3D organ models can be generated in just a minute, significantly reducing the time spent on manual processes. This allows you to concentrate on more intricate delineation tasks rather than squandering valuable resources. Manual contouring often suffers from inter-observer variation, a challenge we address by providing consistent results. As a result, you can effectively reduce the negative consequences that stem from errors in the delineation of anatomical structures. With a single software solution that complies with GDPR regulations, the process of radiotherapy treatment planning has never been more straightforward. Our cloud-based AI model is designed to integrate effortlessly with all hospital systems, enhancing your workflow. MVision AI stands out as an innovative provider of cloud-based software services specifically for radiotherapy treatment planning, setting a new standard in the field. This approach not only improves accuracy but also promotes better patient outcomes in the long run.

VSClinical facilitates the clinical analysis of genetic variants in accordance with ACMG and AMP guidelines. Its structured workflow supports adherence to the American College of Medical Genetics (ACMG) standards, which are essential for identifying and categorizing pathogenic variants related to inherited disease risk, cancer susceptibility, and rare disease diagnosis. The combined ACMG/AMP guidelines for variant interpretation establish a framework for scoring variants and categorizing them into one of five classification levels. Implementing these guidelines necessitates a thorough examination of annotations, genomic contexts, and pre-existing clinical insights for each variant. VSClinical streamlines this process by offering a customized workflow that evaluates each relevant criterion and supplies comprehensive bioinformatics, literature references, and clinical knowledgebase evidence to aid in the scoring and interpretation of variants. This innovative approach is designed to enhance the efficiency of variant scientists as they navigate the complexities of variant processing and analysis. Overall, VSClinical stands out as a vital tool for accelerating the understanding and classification of genetic variants in clinical settings.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

ezMARplus is an innovative tool for medication administration and health monitoring tailored for assisted living environments. This platform streamlines the management of medications, insulin, health assessments, and treatments, all within a single interface. Caregivers can set medication schedules according to individual needs—daily, weekly, or monthly—and can also track vital signs like blood pressure, respiratory rate, and pulse as part of their care routines. The inclusion of an electronic signature feature guarantees that medications and treatments are administered correctly, while customizable MAR and profile printouts aid in maintaining a comprehensive record of these signatures over time. Furthermore, this holistic approach not only enhances efficiency but also improves the quality of care provided to residents.